Traders should monitor upcoming financial disclosures for profitability trends and international expansion potential, as the current data reflects strong top-line growth but does not confirm margins or earnings impact.
Price Chart
Executive Summary
BioHarvest Sciences announced that its VINIA brand has become the #1 resveratrol polyphenol nutraceutical brand in the U.S., driven by its clinically demonstrated ability to improve arterial dilation and blood flow. The company reported over $30 million in U.S. revenue for full-year 2025 and approximately $85 million in global cumulative revenue, with VINIA.com accounting for about 80% of U.S. sales.
Key Facts
- VINIA is now the #1 resveratrol polyphenol brand in the U.S. based on 2025 sales revenue.
- VINIA generated over $30 million in U.S. revenue in full-year 2025.
- Global cumulative revenue for VINIA is approximately $85 million.
- VINIA.com accounts for approximately 80% of U.S. revenue, reflecting strong direct-to-consumer traction.
- The brand has over 85,000 active users in the U.S. and Israel.
- Botanical Synthesis technology enhances piceid resveratrol levels up to 100x compared to natural red grapes.
Financial Impact
Over $30 million in U.S. revenue for 2025 and $85 million in cumulative global revenue, indicating strong commercial execution in the nutraceutical market.
Risk Factors
- Forward-looking statements note that increased revenue does not guarantee net income or profitability due to rising costs.
- Market leadership is based on self-reported data and third-party projections, which may be subject to interpretation.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001723464-26-000014 |
| Document: bhsc_6k.htm | 0001723464-26-000014 |
| Document: 0001723464-26-000014-index-headers.html | 0001723464-26-000014 |
| Document: 0001723464-26-000014-index.html | 0001723464-26-000014 |
| Document: 0001723464-26-000014.txt | 0001723464-26-000014 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 13d ago | 6-K | $1.75 $1.67 | ▼ −4.18% | ▼ −4.64% | $1.68 (−3.72%) |
Oct 8, 2026 18d ago | 6-K | $1.50 $1.70 | ▲ +13.71% | ▲ +13.99% | $1.68 (+12.37%) |
Sep 15, 2026 5w ago | 6-K | $1.66 $1.46 | ▼ −12.05% | ▼ −14.61% | $1.68 (+1.20%) |
Sep 14, 2026 6w ago | 6-K | $1.78 $1.51 | ▼ −14.93% | ▼ −17.04% | $1.68 (−5.35%) |
Jul 15, 2026 14w ago | 6-K | $2.85 $2.18 | ▼ −23.51% | ▼ −22.53% | $1.68 (−41.05%) |
Jun 18, 2026 18w ago | 6-K | $3.26 $2.75 | ▼ −15.64% | ▼ −13.98% | $1.68 (−48.47%) |
May 28, 2026 21w ago | 6-K | $3.90 $3.56 | ▼ −8.72% | ▼ −8.67% | $1.68 (−56.92%) |
May 14, 2026 23w ago | 6-K | $4.16 $3.82 | ▼ −8.17% | ▼ −7.46% | $1.68 (−59.62%) |
May 14, 2026 23w ago | 6-K | $4.16 $3.82 | ▲ +8.17% | ▲ +7.46% | $1.68 (+59.62%) |
May 14, 2026 23w ago | 6-K | $4.16 $3.82 | ▼ −8.17% | ▼ −7.46% | $1.68 (−59.62%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers